Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and...
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and...
MARKET OVERVIEW The irritable bowel syndrome (IBS) market has experienced slow growth owing to a lack of disease understanding, low rate of...
Irritable bowel syndrome (IBS) is a chronic gastrointestinal disorder characterized by alterations in motility, stool consistency and frequency, and...
DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries...
DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries...
DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries...
DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across forty-five ...
DRG Epidemiology's coverage of irritable bowel syndrome comprises epidemiological estimates of key patient populations across 45 countries...
MARKET OUTLOOK IBS-C is an indication ripe for emerging therapies; only three drugs have a label a...
IBS-D is a highly prevalent disorder regularly encountered in general practice that is marked by excessive defecation and abdomi...
Get content updates to your inbox
Subscribe